Leah Smith
Registered Nurse · Man, WVNPI 1841873791
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations.
Across 185 payments — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$399
- AbbVie$394
- GSK$382
- Novo Nordisk$269
- Pfizer$266
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$173
- plus $987 from 15 others
What the payments were for
- Food & beverage$2,870100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $399 |
| AbbVie | 20 | $394 |
| GSK | 25 | $382 |
| Novo Nordisk | 15 | $269 |
| Pfizer | 33 | $266 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $173 |
| Amarin Pharma, Inc. | 11 | $166 |
| Lilly USA, LLC | 8 | $129 |
| Boehringer Ingelheim | 8 | $120 |
| Sumitomo Pharma America, Inc. | 6 | $115 |
| Xeris Pharmaceuticals, Inc. | 5 | $104 |
| Sunovion Pharmaceuticals Inc. | 4 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $54 |
| Dexcom, Inc. | 3 | $48 |
| Bayer | 3 | $47 |
| Almatica Pharma LLC | 3 | $46 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $36 |
| Merck | 1 | $20 |
| Ardelyx, Inc. | 1 | $17 |
| Amgen | 1 | $17 |
| Genentech USA, Inc. | 2 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
Too few registered nurse providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 63 | $70,964 |
| FarxigaDapagliflozin Propanediol | 52 | $37,516 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $21,479 |
| MounjaroTirzepatide | 19 | $19,199 |
| JardianceEmpagliflozin | 23 | $14,429 |
| LinzessLinaclotide | 15 | $12,395 |
| EliquisApixaban | 11 | $9,856 |
| Novolog FlexpenInsulin Aspart | 15 | $4,470 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 107 | $3,553 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 98 | $3,357 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,645 |
| Gabapentin | 162 | $1,781 |
| Ventolin HfaAlbuterol Sulfate | 29 | $1,640 |
| Tramadol Hcl | 55 | $1,384 |
| Sucralfate | 25 | $948 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $269 | $70,96463 claims |
| AstraZenecaFarxiga | $399 | $37,51652 claims |
| GSKTrelegy Ellipta | $382 | $21,47930 claims |
| Lilly USA, LLCMounjaro | $129 | $19,19919 claims |
| Boehringer IngelheimJardiance | $120 | $14,42923 claims |
| AbbVieLinzess | $394 | $12,39515 claims |
| PfizerEliquis | $266 | $9,85611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few registered nurse providers in West Virginiaon file to place this against a meaningful peer group, so we don't.
Other registered nurse in Man
- Angela GrahamPrinceton$2K
- Kayla CorellPrinceton$675
- Nicholas OscanyanMorgantown$360
- Jillanna GillumHuntington$332
- Susan AdkinsCrab Orchard$160
- Angel JacksonDanville$76
- Amy RatkeKeyser$71
- Alexandra MoncadaScott Depot$57
- Amy MooreHuntington$36
- Claire CarusoWheeling$32
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.